Cargando…

Increased Percentage of CD8(+)CD28(−) Regulatory T Cells With Fingolimod Therapy in Multiple Sclerosis

BACKGROUND AND OBJECTIVES: Fingolimod, an oral therapy for MS, decreases expression of membrane S1P1 receptors on CD4(+) memory cells, causing their retention and deactivation in lymph nodes. We determined fingolimod effects on the number and proportion of potentially CNS-damaging CD8(+)CD28(+) cyto...

Descripción completa

Detalles Bibliográficos
Autores principales:	Houston, Timothy W., Howlett-Prieto, Quentin, Regenauer, Colin, Testai, Fernando D., Yao, Faith, Feng, Xuan, Reder, Anthony T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764330/ https://www.ncbi.nlm.nih.gov/pubmed/36535763 http://dx.doi.org/10.1212/NXI.0000000000200075

Ejemplares similares

Adaptive and innate immune responses in multiple sclerosis with anti-CD20 therapy: Gene expression and protein profiles
por: Fong, Chloe C., et al.
Publicado: (2023)

Corrigendum: Adaptive and innate immune responses in multiple sclerosis with anti-CD20 therapy: gene expression and protein profiles
por: Fong, Chloe C., et al.
Publicado: (2023)

Fingolimod Increases CD39-Expressing Regulatory T Cells in Multiple Sclerosis Patients
por: Muls, Nathalie, et al.
Publicado: (2014)

CD28(−) and CD28(low)CD8(+) Regulatory T Cells: Of Mice and Men
por: Vuddamalay, Yirajen, et al.
Publicado: (2017)

Numerical status of CD4(+)CD25(+)FoxP3(+) and CD8(+)CD28(-) regulatory T cells in multiple sclerosis
por: Kouchaki, Ebrahim, et al.
Publicado: (2014)

Lenalidomide overcomes the immunosuppression of regulatory CD8(+)CD28(−) T-cells
por: Neuber, Brigitte, et al.
Publicado: (2017)

CD28 engagement inhibits CD73-mediated regulatory activity of CD8(+) T cells
por: Lai, Yo-Ping, et al.
Publicado: (2021)

Percentage and function of CD4(+)CD25(+) regulatory T cells in patients with hyperthyroidism
por: Jiang, Ting-Jun, et al.
Publicado: (2018)

The Direct Effects of Fingolimod in the Central Nervous System: Implications for Relapsing Multiple Sclerosis
por: Hunter, Samuel F., et al.
Publicado: (2015)

Fingolimod alters the transcriptome profile of circulating CD4+ cells in multiple sclerosis
por: Friess, Jörg, et al.
Publicado: (2017)

Harnessing CD8(+)CD28(−) Regulatory T Cells as a Tool to Treat Autoimmune Disease
por: Ceeraz, Sabrina, et al.
Publicado: (2021)

People with HIV have higher percentages of circulating CCR5+ CD8+ T cells and lower percentages of CCR5+ regulatory T cells
por: van Eekeren, Louise E., et al.
Publicado: (2022)

Mechanism of Action and Clinical Potential of Fingolimod for the Treatment of Stroke
por: Li, Wentao, et al.
Publicado: (2016)

Divide, Conquer, and Sense: CD8(+)CD28(−) T Cells in Perspective
por: Arosa, Fernando A., et al.
Publicado: (2017)

Human mesenchymal stromal cells enhance the immunomodulatory function of CD8(+)CD28(−) regulatory T cells
por: Liu, Qiuli, et al.
Publicado: (2015)

Elevated Percentage of CD3(+) T-Cells and CD4(+)/CD8(+) Ratios in Multiple System Atrophy Patients
por: Cao, Bei, et al.
Publicado: (2020)

Fingolimod treatment modulates PPARγ and CD36 gene expression in women with multiple sclerosis
por: Ferret-Sena, Véronique, et al.
Publicado: (2022)

The Role of CD28 and CD8(+) T Cells in Keloid Development
por: Shan, Mengjie, et al.
Publicado: (2022)

CD3(+)CD8(+)CD28(−) T Lymphocytes in Patients with Lupus Nephritis
por: Żabińska, Marcelina, et al.
Publicado: (2016)

Decreased CD8(+)CD28(+)/CD8(+)CD28(–) T cell ratio can sensitively predict poor outcome for patients with complicated Crohn disease
por: Dai, Shi-xue, et al.
Publicado: (2017)

Percentages of CD4+CD161+ and CD4−CD8−CD161+ T Cells in the Synovial Fluid Are Correlated with Disease Activity in Rheumatoid Arthritis
por: Miao, Jinlin, et al.
Publicado: (2015)

Streptococcus pneumoniae Serotype 1 Capsular Polysaccharide Induces CD8(+)CD28(−) Regulatory T Lymphocytes by TCR Crosslinking
por: Mertens, Janina, et al.
Publicado: (2009)

Distribution and clinical significance of circulating CD8(+)CD28(−) regulatory T cells in the peripheral blood of patients with pulmonary tuberculosis
por: Yu, Xin, et al.
Publicado: (2022)

Circulating cytotoxic CD8(+) CD28(-) T cells in ankylosing spondylitis
por: Schirmer, Michael, et al.
Publicado: (2002)

Protective role of fingolimod (FTY720) in rats subjected to subarachnoid hemorrhage
por: Xu, Hao-Liang, et al.
Publicado: (2015)

Prognostic significance of peripheral CD8+CD28+ and CD8+CD28− T cells in advanced non-small cell lung cancer patients treated with chemo(radio)therapy
por: Liu, Chao, et al.
Publicado: (2019)

Determination of Seminal Concentration of Fingolimod and Fingolimod‐Phosphate in Multiple Sclerosis Patients Receiving Chronic Treatment With Fingolimod
por: David, Olivier J., et al.
Publicado: (2017)

Increased percentage of apoptotic and CTLA-4 (CD152) expressing cells in CD4(+)/CD8(+) cells in COVID-19 patients
por: Zahran, Asmaa M., et al.
Publicado: (2022)

Restoration of CD28 Expression in CD28(−) CD8(+) Memory Effector T Cells Reconstitutes Antigen-induced IL-2 Production
por: Topp, Max S., et al.
Publicado: (2003)

The Evolving Role of CD8(+)CD28(−) Immunosenescent T Cells in Cancer Immunology
por: Huff, Wei X., et al.
Publicado: (2019)

Percentage of Peripheral CD19+CD24hiCD38hi Regulatory B Cells in Neonatal Sepsis Patients and Its Functional Implication
por: Pan, Xiao, et al.
Publicado: (2016)

Development of Exhaustion and Acquisition of Regulatory Function by Infiltrating CD8+CD28− T Lymphocytes Dictate Clinical Outcome in Head and Neck Cancer
por: Fenoglio, Daniela, et al.
Publicado: (2021)

CD4+CD25(high), CD8+CD28– cells and thyroid autoantibodies in breast cancer patients
por: Biylgi, Oğuz, et al.
Publicado: (2014)

Vitamin D enhances responses to interferon-β in MS
por: Feng, Xuan, et al.
Publicado: (2019)

CD28 Costimulation Is Required for In Vivo Induction of Peripheral Tolerance in CD8 T Cells
por: Vacchio, Melanie S., et al.
Publicado: (2003)

Patients With Severe Multiple Sclerosis Exhibit Functionally Altered CD8(+) Regulatory T Cells
por: Benallegue, Nail, et al.
Publicado: (2022)

CD8(+) T Regulatory Cells in Lupus
por: Singh, Ram P., et al.
Publicado: (2021)

Modulation of Regulatory T Cells Activity by Distinct CD80 and CD86 Interactions With CD28/CTLA-4 in Chagas Cardiomyopathy
por: Pinto, Bruna F., et al.
Publicado: (2022)

CD28-signaling can be partially compensated in CD28-knockout mice but is essential for virus elimination in a murine model of multiple sclerosis
por: Hülskötter, Kirsten, et al.
Publicado: (2023)

Poor Immune Reconstitution in HIV-Infected Patients Associates with High Percentage of Regulatory CD4(+) T Cells
por: Horta, Ana, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ds4ovn8aqeulqfrj272rqpjm5p